In Leishmania major, the core of the abundant surface lipophosphoglycan (LPG) is structurally related to that of the smaller glycosylinositolphospholipids (GIPLs) in containing galactosylfuranose (Gal f ) residues in a Gal f (␤1, 3)Man motif. However, deletion of the putative Gal f -transferase (Gal f T) LPG1 affected Gal f incorporation in LPG but not GIPLs. We hypothesized that the presumptive GIPL Gal f -transferases could be homologous to LPG1, and identified three related genes in the L. major genome. These were termed LPG1L, LPG1R, and LPG1G, the latter of which was found in three identical copies located at the telomeres of chromosomes 5, 19, and 32 based on Leishmania genome project data. Neither LPG1 nor its homologues LPG1L and LPG1R were involved in the biosynthesis of GIPLs, as an lpg1 − /lpg1l − /lpg1r − triple knockout (the first such in Leishmania) grew normally and made wild-type levels of Gal f -containing GIPLs. In contrast, overexpression of these three led to elevated galactose incorporation in glycoproteins. Gal f -containing glycoproteins had not been described in Leishmania but occur at high levels in other closely related trypanosomatids including Trypanosoma cruzi, Crithidia, Leptomonas, and Endotrypanum, and LPG1L and LPG1R homologs were detected in these species. These data suggest that the glyco-synthetic capabilities of Leishmania and perhaps other trypanosomatids may be larger than previously thought, with some activities being 'cryptic' in different lineages and potentially serving as reservoirs for glycoconjugate variation during evolution. Future tests will address whether the LPG1G family encodes the hypothesized GIPL-specific Gal f T.
Introduction
Protozoan parasites of the genus Leishmania are the causative agent of the disease leishmaniasis, which infects more than 10 million people worldwide [1] . Leishmania parasites are transmitted through sand fly bites, where the flagellated promastigote cells are introduced into the mammalian host. Parasites are then taken up by macrophages and differentiate into the non-flagellated amastigotes. Depending on parasite species, Leishmania infections in humans cause manifestations from self-containing cutaneous lesions to lethal visceral infections.
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The surface of the promastigote stages of Leishmania is coated with a variety of interrelated glycoconjugates including lipophosphoglycan (LPG), glycosylinositolphospholipids (GIPLs), proteophosphoglycan (PPG), and GPI-anchored proteins [2] [3] [4] . In the sand fly, stage-specific modifications of LPG are responsible for the attachment and release of promastigotes from the midgut [5] [6] [7] . In the mammalian host, LPG confers resistance to complement-mediated lysis, oxidative stress, and inhibits phagolysosomal fusion [8, 9] . However, LPG is down-regulated in amastigotes, whose surface is dominated instead by the abundant GIPLs, which suggested that these play critical roles in amastigote survival and virulence [10, 11] . This view was recently called into question by studies of a Leishmania major mutant lacking the enzyme alkyldihydroxyacetone phosphate synthase (ADS1), which is required for the synthesis of ether phospholipids. The ads1 − null mutant lacked LPG and GIPLs but maintain the presence of GPI-anchored proteins, probably bearing a modified GPI anchor [12] . Remarkably, ads1 − mutants showed little phenotype beyond that attributable to loss of LPG (e.g. reduced ability to establish macrophage infections), and ads1 − amastigotes can replicate in macrophages and cause disease in susceptible mice [12] . In L. mexicana, there are conflicting data about the role of GIPLs in parasite viability and/or virulence [13] [14] [15] . A potential drawback is that the various Leishmania mutants studied were pleiotropic and affected a number of glycoconjugates, making inferences about GIPL function indirect. Thus, the identification of genes that specifically affect GIPL synthesis would simplify and strengthen genetic studies of their function.
Leishmania GIPLs have different structures in different species, consisting of type I GIPLs whose structure resembles that of protein GPI anchors, type II GIPLs whose structure resembles that of the LPG core, and/or "hybrid" GIPLs [3, 10, 11] . L. major synthesize primarily type II GIPLs, which contain galactosylfuranose (Gal f ) in the Gal 0-2 Gal f (␤ 3 )Man sequence, which is also found in the LPG core ( [16, 17] , Fig. 1 ). We showed previously that LPG1, encoding a putative galactofuranosyl transferase (Gal f T), was responsible for adding Gal f to the LPG core structure, but that lpg1 − mutants continued to synthesize the Gal f -containing GIPLs [18] . Thus, there must be additional Gal f Ts that are responsible for the synthesis of GIPLs. Given the similarity of the Gal f T acceptors for LPG and GIPLs, it seemed reasonable to postulate that these GIPL-specific Gal f Ts could be related to LPG1. In this report we describe the characterization of a family of LPG1 homologs in the L. major genome, and studied the effect of genetic inactivation of three of these singly or in combinations (LPG1, LPG1L, and LPG1R).
Materials and methods

Leishmania cultures
L. major LV39 clone 5 (Rho/SU/59/P) cells were grown in M199 medium supplemented with 10% heat inactivated fetal calf serum at 26 • C [19] . Selective drugs used in this study included G418 (10 g/ml), hygromycin (50 g/ml), puromycin (10 g/ml), nourseothricin (80 g/ml), blasticidin (10 g/ml), and phleomycin (10 g/ml).
Isolation of LPG1L and LPG1R open reading frames
At the time these studies were initiated the L. major genome was largely incomplete. Sequence data was obtained from the Sanger Institute website at http://www.sanger. ac.uk/Projects/L major/. Searches with LPG1 first identified a 537-bp region from the Leishmania Genome Database; this region was PCR amplified and used to identify a cosmid (B4308) containing the full length gene from a cLHYG genomic cosmid library made from L. major Friedlin strain V1 (MHOM/IL/80/Friedlin). This gene was termed LPG1L (for LPG1-like) and its open reading frame and flanking regions were sequenced (GenBank accession number AY235572). A second gene termed LPG1R (LPG1-related) was similarly identified in the Leishmania Genome Database; this ORF and flanking sequences were recovered by PCR and their sequences were determined (AY235573). Preliminary sequence data from T. cruzi was obtained from The Institute of Genomic Research through their website at http://www.tigr.org.
Molecular constructs
To generate the C-terminal GFP tagged proteins, full length open reading frames lacking stop codons were PCR amplified from L. major FV1 genomic DNA using primers SMB1307 (5 -TTATCAggatccACCATGAAGGGCAGAC-TAC-3 , lower case letters indicate added restriction sites) and SMB1310 (5 -ATATAAgcggccgcCGGGCTGACAGC-CTGCAG) for LPG1L and SMB1354 (5 -TATAGCggatccA-CCATGAAGCGCGGGCAGAGG) and SMB1405 (5 -ACAGCTgatatcCTTTCGCCAATCCGGCTCTG) for LPG1R. The resulting DNA fragments were digested with appropriate restriction enzymes (BamHI and NotI for LPG1L, BamHI and EcoRV for LPG1R) and cloned into the expression site of pXG−/GFP+ (a vector for making C-terminal GFP fusion proteins; strain B2863 [20] ) to make pXG-LPG1L-GFP (B4400) and pXG-LPG1R-GFP (B4455).
To make deletion constructs for LPG1L, a 700-bp region immediately upstream of the start codon and a 900-bp region immediately downstream of the stop codon of LPG1L were PCR amplified from L. major genomic DNA and cloned into vector pX63PAC (B1129) [21] so that the end of the upstream region is linked to the beginning of the downstream region. Next a 909-bp NEO marker gene (confers resistance to G418) was excised from vector pXG (B4090) [20] and inserted in between the upstream and downstream regions of LPG1L to make pX63PAC-KO-LPG1L:NEO (B4369). Similarly, a 1052-bp HYG marker gene (conferring resistance to hygromycin) was excised from vector pX63HYG (B617) [22] using SpeI and BamHI and inserted in between the upstream and downstream regions of LPG1L to make pX63PAC-KO-LPG1L:HYG (B4370). Linear deletion cassettes containing NEO and HYG markers flanked by the upstream and downstream regions of LPG1L were generated by SmaI digestion.
To make deletion constructs for LPG1R, first a 2.4-kb DNA fragment containing the LPG1R ORF (plus sequences 550 bp from upstream and 440 bp from downstream) was PCR amplified from L. major genomic DNA and cloned into vector pUC18 to give pUC-LPG1R (B4413). Then a SacII/SphI fragment containing the first 500 bp of LPG1R ORF was replaced by drug markers (PAC or SAT, conferring resistance to puromycin or nourseothricin, respectively) amplified by PCR. The resulting constructs, pUC-KO-LPG1R:PAC (B4451) and pUC-KO-LPG1R:SAT (B4513) were digested with EcoRI and HindIII to generate linear deletion cassettes for LPG1R.
Previously, a 4.2-kb fragment containing the LPG1 ORF and flanking sequences was cloned into the BamHI site of vector pUC18 (pUC-LPG1-Bam, B2880). To make the deletion construct for LPG1, the first 700 bp from LPG1 ORF was replaced by the BSD (confers resistance to blasticidin) marker gene. The resulting construct, pUC-KO-LPG1:BSD (B4573), was digested with BamHI to generate a linear knockout cassette for LPG1.
An overexpression construct for LPG1, LPG1L, and LPG1R was made in three steps. First, the full-length LPG1L gene was cloned in the BglII site of vector pIR1PHLEO (B4054) derived from pIR1SAT (B3541; [23] ) to make pIR1PHLEO-LPG1L (B4587). Second, the full-length LPG1R gene was cloned in the BamHI site of pIR1PHLEO-LPG1L (B4589). The resulting construct, pIR1PHLEO-LPG1L-LPG1R, was linearized with NsiI and blunt ended, followed by ligation with the 4.2-kb LPG1 fragment (BamHI digestion of pUC-LPG1-Bam then blunt ended) to generate pIR1PHLEO-LPG1-LPG1L-LPG1R (B4789).
Genetic manipulations
Leishmania were transfected by electroporation as described [24] . Typically, 5-10 g of DNA was used for each transfection. Transfected cells were plated on medium containing 1% noble agar and appropriate concentrations of selective drugs. To study the localization of LPG1L and LPG1R, L. major cells containing pX63HYG-LPG2-HA (a marker of the parasite Golgi apparatus; strain B1878 [22] ) were transfected with pXG-LPG1L-GFP (B4400) or pXG-LPG1R-GFP (B4455) and selected with hygromycin and G418. The lpg1 − lpg1l − /lpg1r − triple knockout parasites were created using a loss-of-heterozygosity (LOH) approach [25] . Briefly, the first allele of LPG1 in the lpg1l − /lpg1r − double knockout was replaced by the BSD marker. After two passages in the presence of 50 g/ml of blasticidin, cells were incubated in media containing 10 g/ml of galactose-binding lectin ricin RCA120 (Sigma) at 10 7 cells/ml. Cells that failed to agglutinate were plated, and ∼80% of the resulting colonies had lost the second allele of LPG1. All knockout strains were confirmed by Southern-blot analysis.
Molecular biology techniques
Southern-blot and Northern-blot analyses were performed as previously described [26] . The Southern blot shown in Fig. 9 was subsequently washed first in 2× SSPE/0.5% SDS for 15 min at room temperature, and then three times in 0.2× SSPE/0.5% SDS at 60 • C for 15 min each. RT-PCR analysis was used to map the mRNA splicing acceptor sites of LPG1L and LPG1R. Briefly, first strand synthesis was performed using gene-specific antisense primers SMB1228 (5 -GCGTGTCGCCATTTTGGGCGAG) for LPG1L and SMB1369 (5 -CCGCAGCGCGCAGCTTCGTC) for LPG1R. Reverse transcription was performed at 42 • C with AMV reverse transcriptase (Sigma) and 2 g of total RNA, followed by PCR amplification with the first strand primers plus the universal miniexon primer SMB936 (5 -AACGCTATATAAGTATCAGTTCTGTACTTTA) for L. major [27] . The resulting fragments were sequenced to map the mRNA splice acceptor sites.
Western blots and fluorescence microscopy
Log phase (1-5 × 10 6 cells/ml) cell extracts and culture supernatants were resolved by SDS/PAGE and electroblotted onto Hybond ECL nitrocellulose membranes (Amersham Biosciences). Mouse monoclonal antibody WIC79.3 [28] was used to detect LPG and PPG (1:1000 dilution). Mouse anti-L. major GP63 monoclonal antibody [29] was used to detect GP63 (1:1000 dilution). Mouse monoclonal anti-␣-tubulin antibody (T5168, Sigma) was used to detect ␣-tubulin (1:10000 dilution). An enhanced chemiluminescence (ECL) detection system (Amersham) was used to detect signals. For fluorescence microscopy, log phase cells were immobilized on polylysine coated cover slips, followed by fixation with 3.5% formaldehyde in PBS. After being permeated by 100% ethanol at 4 • C, cells were incubated with dilutions of primary and secondary antibodies as described [30] .
Mouse footpad infections
Parasite virulence was evaluated by mouse footpad infections. Briefly, all parasite lines were first inoculated at high levels (2 × 10 7 ) into BALB/c mice in order to guard against effects arising from transfection/culture passage associated loss of virulence. They were recovered after 1 month prior to emergence of pathology, and converted into promastigotes in vitro. After three passages in culture, stationary phase parasites (day 3) were resuspended in DMEM media at 2 × 10 7 cells/ml and 10 6 were injected into the footpads of 8-week-old female BABL/c mice (5-6 mice per group). Lesion sizes were measured weekly with a Vernier caliper and parasite numbers in the infected foot pads were determined by limiting dilution assay [31] .
GIPL analysis
Exponentially growing cells were metabolically labeled with [ 3 H]galactose (50 Ci for 8 × 10 8 cells) for 16 h, and [ 3 H]GIPLs were purified as described [32] . The [ 3 H]GIPLs were treated with 0.04 M trifluoroacetic acid for 1 h at 100 • C to cleave the labile galactofuranosidic bonds, and the [ 3 H-Gal]fragments were chromatographed on paper as described [33] . Other aliquots of unlabeled GIPLs were subjected to nitrous acid deamination [33] to remove the lipid anchors, tagged at the reducing end with the fluorophore 9-aminonaphthalene 1,3,6-trisulfate, and analyzed by GLYKO-FACE electrophoresis according to the manufacturer's specifications (GLYKO, Novato, CA).
LPG and glycoprotein analysis for the LPG1-LPG1L-LPG1R overexpressors
Parasites (5 × 10 6 cells/ml) were metabolically labeled for 16 h with [6-3 H]galactose (50 Ci) in 5 ml of M199 culture medium supplemented with 10% fetal calf serum and 1 g/ml of biopterin. [ 3 H]LPG was solubilized by differential organic solvent extraction and removed by chromatography on phenyl-Sepharose as described [38] . The insoluble residue containing [ 3 H]glycoproteins was converted to [ 3 H]glycopeptides by digestion with Pronase as described [34] and desalted by chromatography on Sephadex G25. Maltohexose (1 mole) was added to the protein residue prior to Pronase digestion as an internal standard and was quantitated by capillary electrophoresis using conditions: 20 • C, 20 psi, and 20 min.
Results
Identification of a family of six LPG1-related genes in L. major
Search for sequences with similarity to L. major LPG1 revealed the presence of fragments from related sequences in the L. major (Friedlin V1 strain) genome project data, which was then incomplete. The sequence for two of these genes, designated LPG1L (LPG1-like) and LPG1R (LPG1-related), was determined. Southern-blot analysis and gene deletion studies showed that these genes occurred in a single copy (data not shown or below). As these studies were being finished, the emerging L. major genome sequence revealed three additional related homologous genes that were named LPG1G, whose predicted amino acid sequences were identical and located on chromosomes 5, 19, and 32 (LmjF05.1230, LmjF19.650, and LmjF32.3900; sequence information is available at http://www.genedb.org/genedb/leish/index.jsp). Southern-blot analysis confirmed the presence of multiple LPG1G genes in L. major strain LV39 clone 5 as well (data not shown). Interestingly, all three of the L. major Friedlin strain LPG1G genes appear to be located adjacent to telomeres. LPG1 has been described in several Leishmania species previously [35, 36] ; preliminary analysis of data arising from shotgun sequence of L. infantum suggest that this species also has homologs of LPG1L, LPG1R, and at least one copy of LPG1G, all of which show >90% identity to the homologous gene of L. major (data not shown).
Properties of predicted LPG1-family proteins
The predicted open reading frames for LPG1, LPG1L, LPG1R, and LPG1G contained 434, 592, 460, and 599 amino acids, respectively. All four genes (LPG1, LPG1L, LPG1R, and LPG1G) were predicted to encode type-II transmembrane proteins with short, basic cytoplasmic tails (∼20 amino acids) at the N-termini, followed by single transmembrane domains ( Fig. 2A ; predictions were made using the TMHMM Server at http://www.cbs.dtu.dk/services/ TMHMM/). Relative to LPG1, there were insertions in LPG1L (encoding amino acid 43-161) and LPG1G (encoding amino acid 43-149) immediately after the transmembrane domain, that were not seen in LPG1 or LPG1R ( Fig. 2A and B) . The overall similarity among these four genes was modest (∼20% amino acid identity; Fig. 2B) . Nonetheless, the predicted lumenal domains of all four genes contained several highly conserved regions as shown in the alignment in Fig. 2B . One of these regions
is likely to represent the catalytic site, since it contained the metal-binding DXD motif conserved amongst glycosyltransferases ( Fig. 2A and B) .
In all following studies we focused exclusively on the characterization of LPG1L and LPG1R.
Detection of LPG1L and LPG1R mRNA in L. major
To test whether LPG1L and LPG1R were expressed in L. major, total RNA was prepared from early log phase, late log phase, stationary phase, metacyclic phase, and amastigote Northern-blot analysis was performed as described in Section 2. Probes were made from coding regions of LPG1L and LPG1R. E, early log phase; L, late log phase; S, stationary phase; M, metacyclic phase (prepared by negative selection for binding with peanut agglutinin; [53] ); A, amastigotes (from infected mouse foot pads). Expression of rRNA was used as controls for loading.
stage cells and subjected to Northern-blot analysis using the coding regions of LPG1L and LPG1R as probes. The 2.8-kb LPG1L and 2.0-kb LPG1R mRNAs were expressed at similar levels throughout parasite life cycle (Fig. 3) . RT-PCR analysis mapped the site of trans-splicing sites for LPG1L and LPG1R to positions 129 and 160 nt upstream of the ATG start codon for LPG1L and LPG1R, respectively (data not shown).
Cellular localization of LPG1L and LPG1R
Previous data showed that an LPG1::GFP fusion protein was localized in the Golgi apparatus in Leishmania [20] . To examine the cellular localization of LPG1L and LPG1R gene products, we created similar fusion constructs joining the green fluorescent protein (GFP) to the C-termini of LPG1L and LPG1R. When expressed in Leishmania from episomal pXG vectors, both LPG1L::GFP and LPG1R::GFP fusion proteins showed strong green fluorescence in a region close to the kinetoplast, the location of the Golgi apparatus. To confirm Golgi localization, we introduced a construct expressing a hemagglutinin (HA)-tagged LPG2 gene, which encodes a Golgi GDP-mannose transporter [22, 37] . Immunofluorescence analysis of the LPG2::HA showed co-localization with the LPG1L::GFP and LPG1R::GFP signals (Fig. 4) . This 
and pXG-LPG1L-GFP (A-D) or pXG-LPG1R-GFP (E-H)
. Localizations of LPG1L and LPG1R were determined by GFP fluorescence (C and G, respectively). The golgi apparatus was revealed by staining cells with rabbit anti-HA polyclonal antibody, followed by Texas Red-labeled mouse anti-rabbit monoclonal antibody (B and F). Hoechst 33258 dye was used to stain DNA (both nuclear and kinetoplast). D: merge of B and C; H: merge of F and G. result was further confirmed by immuno-EM study using anti-GFP antibody (data not shown). Therefore, similar to LPG1, the gene products of LPG1L and LPG1R were also localized at the Golgi apparatus, consistent with the cellular location of most glycosyltransferases.
Generation of double and triple LPG1, LPG1L and LPG1R knockouts
Because Leishmania has a diploid genome, two rounds of replacement are required to inactivate any given gene. This presents an obstacle in genetically assessing the function of all six members of the LPG1 gene family, as currently just six suitable markers exist. Here we studied the effects of inactivation of LPG1L and LPG1R, singly, together, or in combination with LPG1. An outline of the gene inactivation protocol is shown in Fig. 5A . Briefly, LPG1L alleles were replaced by HYG and NEO markers (as lpg1l − ), while LPG1R alleles were replaced by PAC and SAT markers (as lpg1r − ), and all four alleles were replaced in the double lpg1r − /lpg1l − mutant. The triple knockout parasites (lpg1 − /lpg1l − /lpg1r − ) were generated through a LOH approach [25] , by first replacing one LPG1 allele of the lpg1l − /lpg1r − mutant with the BSD marker, then selecting for the loss of LPG. In all lines, Southern-blot analysis confirmed that the planned replacements had occurred; data for the lpg1 − /lpg1l − /lpg1r − triple knockout parasite is shown in Fig. 5B .
The single, double and triple knockout parasites grew at similar rates as L. major wild-type cells in culture (data not shown). Western-blot analysis showed that all lines tested synthesized wild-type levels of PPG and GP63, and that the lpg1l − , lpg1r − , and lpg1l − /lpg1r − mutants synthesized WT levels of LPG (Fig. 6 and data not shown) . These data indicated that LPG1L and LPG1R were not involved in the synthesis of large surface glycoconjugates such as LPG, PPG, or the GPI-anchored protein GP63. Additionally, expression of LPG1L and LPG1R from episomal vectors did not restore the synthesis of LPG in the lpg1 − mutant, arguing that LPG1L and LPG1R could not substitute for the function of LPG1 even when overexpressed (data not shown).
Deletion of LPG1L and/or LPG1R did not affect the biosynthesis of GIPLs
The effect of LPG1-family mutants on GIPL synthesis was evaluated in two ways. First, total GIPL fractions from wild type and mutant cells were extracted, dilipidated, fluorophore-labeled, and analyzed by FACE (fluorophore-assisted carbohydrate electrophoresis). GIPLs from single (lpg1l − , lpg1r − ) or double (lpg1l − /lpg1r − ) knockouts showed a pattern similar to the GIPL pattern seen for wild type (Fig. 7A and data not shown) . In contrast, the GIPL pattern for the triple knockout (lpg1 − /lpg1l − /lpg1r − ) containing the deletion of LPG1 showed a pattern similar to the lpg1 − knockout alone (Fig. 7A) . Accumulation of the expected LPG biosynthetic intermediate (Glc-P-Man 2 -GlcN) was observed in all lines bearing the homozygous lpg1 − deletions. Second, cells were metabolically labeled with [ 3 H]galactose and total GIPLs were extracted and treated with trifluoroacetic acid to cleave the Gal f -Man linkage in GIPLs with the structure Gal 0-2 -Gal f -Man-Man-GlcN. After separation by paper chromatography, similar profiles were seen in WT and all mutant lines (Fig. 7B and data not  shown) . Therefore, it is unlikely that any of genes (LPG1, LPG1L, and LPG1R) were involved in the biosynthesis of the Gal f -containing type-II GIPLs in L. major.
LPG1L and LPG1R were not required for metacyclogenesis nor mouse infectivity
The percent metacyclic promastigotes (infectious form) present in stationary phase cultures showed very little difference amongst the wild type and various knockout cells (data not shown). To test if LPG1L and/or LPG1R were implicated in virulence, stationary phase parasites were inoculated in susceptible BABL/c mice. There was no significant difference in lesion formation between wild type and various knockout cells (lpg1l − , lpg1r − , and lpg1l − /lpg1r − ), arguing that LPG1L and LPG1R were not required for virulence in the mammalian host (Fig. 8) .
Potential role of LPG1L and LPG1R in adding Gal f to glycoproteins
Since neither LPG1L nor LPG1R appeared to function in GIPL biosynthesis, we asked whether these genes might participate in other glycoconjugate synthetic pathways. Gal f residues are not synthesized by the mammalian hosts, but are found in glycoconjugates synthesized by a number of pathogens including Mycobacterium, T. cruzi, and Aspergillus [38] [39] [40] . In Leishmania, Gal f residues have only been found in glycolipids [41] . In contrast, other Kinetoplastid species such as T. cruzi, Crithidia fasculata, Leptomonas samueli, and Endotrypanum schaudinni contain abundant amounts of Gal f residues in their glycoproteins, often ␤1, 3-linked to mannose as in the LPG and GIPLs in L. major [38, [42] [43] [44] . Southern-blot analysis was performed on the genomic DNA from the species mentioned above using the coding regions of LPG1, LPG1L, and LPG1R from L. major as probes. After several washes at moderate stringy (Section 2), strong signals were seen for several of these LPG1 family members in all species (Fig. 9) . Additionally, LPG1-related genes have been identified in the emerging genome sequence of T. cruzi (Fig. 2) . Since Gal f had never been observed previously in Leishmania proteins, we undertook an overexpression approach to determine whether LPG1 and its homologues (LPG1L and LPG1R) had any effect on protein galactosylation. In these studies, we generated a construct which simultaneously expressed LPG1, LPG1L, and LPG1R and integrated it into the ribosomal RNA locus of L. major, a position which gives high levels of expression [23] . WT and transfectants were metabolically labeled with [ 3 H]galactose, and incorporation of the radiolabel into glycoproteins was measured. The results showed a small but reproducible increase in protein galactosylation (Fig. 10A) . Efforts to assign this activity to either LPG1, LPG1R, or LPG1L in single gene overexpressors were inconclusive, possibly due to the low level of incorporation.
Unlike several other protozoans, the presence of Gal f in N-linked carbohydrate chains in L. mexicana has been investigated and was not detected [45, 46] , possibly due to the low abundance of the monosaccharide. To examine whether L. major might possess Gal f -containing proteins, [ 3 H-Gal]glycopeptides were prepared by Pronase digestion of glycoproteins from wild-type cells and aliquots were incubated in the presence or absence of exo-␤-galactofuranosidase [47] , desalted by anion exchange that removes most of the glycopeptides, and analyzed ]galactose and glycopeptides were extracted as described in Section 2. Radioactivity in these glycoproteins was determined using a scintillation counter; several experiments were done and the results of one with three replicas is shown; error bars represent standard deviation. (B) Demonstration of terminal Gal f residues in L. major glycoproteins. [ 3 H-Gal]Glycoproteins from LV39 WT cells were digested with pronase and desalted [25] , and 10,000 cpm were incubated in the presence or absence of exo-␤-galactofuranosidase [47] . After 24 h of incubation at 37 • C, the samples were applied to a column (2 ml) of Dowex AG1-X8 (acetate) over Dowex AG50-X8 (hydrogen) and the eluent was subjected to descending chromatography on paper using the solvent n-butanol:pyridine:water (6:4:3 
Discussion
In this study we described the LPG1 gene family of L. major, and reported detailed characterization of two of the genes, LPG1L and LPG1R. The five new genes predict proteins showing strong similarity to the active LPG-specific Gal f T encoded by LPG1, in being type II transmembrane glycoproteins with a short N-terminal cytoplasmic domain and a lumenal C-terminal domain bearing a canonical glycosyltransferases DXD motif ( Fig. 2A) . Both LPG1R and LPG1L are constitutively expressed in stable mRNA throughout the parasite life cycle (Fig. 3) . Furthermore, episomally expressed LPG1L and LPG1R-GFP fusion proteins localized to the parasite Golgi apparatus (Fig. 4) . Thus, these genes were reasonable candidates to be the GIPL-specific Gal f transferase postulated previously [9] , and their modest degree of overall sequence conservation (∼20% identity) provides the requisite opportunity for divergence in Gal f T acceptor specificity.
Due to the late emergence of the three LPG1G gene sequences and the availability of only six selectable genetic markers, we focused functional studies on the LPG1, LPG1L, and LPG1R genes. Single and double mutants of LPG1L and LPG1R were made, and a mutant lacking all three was also constructed, the first such triple knockout mutant reported in Leishmania (Fig. 5) . These studies showed collectively that LPG1L and LPG1R had no effect on parasite growth, differentiation or the ability to induce disease in animals (Fig. 8) . Analysis of glycoconjugate synthesis showed similarly that loss of LPG1L and LPG1R had no effect on the synthesis of the abundant glycoconjugates GP63, PPG, or LPG (Fig. 6) . Lastly, while the triple mutant showed the expected adverse effect on LPG synthesis due to deletion of the LPG1 gene, there was no effect on GIPL biosynthesis (Fig. 7) . These data suggest that none of these three genes are essential for the GIPL-specific Gal f T. Obviously, the proposal that the LPG1G genes encode this activity is attractive, but the possibility that a completely unrelated gene encodes this activity cannot be excluded. It is interesting that L. infantum appears to contain an LPG1G homolog; while the GIPL composition of this species isolate has not been investigated, its close relative L. donovani lacks Gal f -containing GIPLs [11] . While we were unable to test the effect of LPG1G knockouts in these studies, our repertoire of six selectable markers will be sufficient to permit the eventual inactivation of all three LPG1G genes simultaneously in the future.
In L. major Gal f residues are present almost exclusively in glycolipids such as LPG and GIPLs, whereas in other trypanosomatid species other glycoconjugates contain Gal f similarly linked to Man [38, [42] [43] [44] . This suggested that perhaps one or more of the LPG1 family members participate in Gal f T reactions involving other acceptors including the carbohydrate chains of proteins. Although Parodi and coworkers reported that L. mexicana lacks Gal f -containing glycoproteins [45, 46] , a low abundance of this substituent was not excluded. Consistent with the possibility of Gal f in Leishmania glycoproteins, several species known to express Gal f -containing proteins possess genes homologous to LPG1, LPG1L, and LPG1R (Fig. 9) , and the T. cruzi genome project also has revealed a family of LPG1-homologs (http://www.tigr.org/tdb/e2k1/tca1/). Significantly, simultaneous overexpression of LPG1, LPG1R, and LPG1L resulted in increased incorporation of galactose into L. major proteins (Fig. 10) , at least some of which was in the form of terminal Gal f . Although we were unable to assign this function to a single gene, it is likely that one or more of the LPG1-family genes encode proteins with protein-glycoconjugate Gal f T activity. This would be especially relevant to studies of T. cruzi, where the abundant mucins are highly modified by Gal f and are thought to contribute to parasite virulence [48, 49] .
One scenario consistent with our data is that Leishmania LPG1L and LPG1R may be cryptic, relatively "silent counterparts" of genes highly active in other trypanosomatids. This further suggests that the potential genomic glyco-synthetic repertoire of these parasites may be larger than revealed by biochemical assays, which typically focus on the most abundant molecules or subsets thereof. A similar finding was reached in studies of the SCG family of LPG side chain galactosyltransferases, as only a subset of the seven genes of this family have shown significant GalT activity [6] . The presence of a number of silent but potentially active glycosyltransferases genes is intriguing and raises a number of speculative possibilities. Potentially, these genes represent a source for the emergence of novel or modified glycoconjugate synthesis during evolution, which may contribute in any number of ways to parasite virulence and host range. In protozoa such as Plasmodium or Trypanosoma variant surface proteins represent an interesting analogy, as gene families in these organisms comprise a group of cryptic genes that are expressed in various ways amongst strains and species and contribute to pathology [50] [51] [52] . In these species many such genes are located at telomeres and it is interesting to note that the three LPG1G genes appear to be located at telomeres in L. major and L. infantum (unpublished data; Leishmania Genome Project). Presumably during the evolutionary divergence of trypanosomatids, different lineages have chosen to emphasize the synthesis of particular glycoconjugates relevant to their biological niche within the mammalian and insect hosts. This raises the possibility that this cryptic glyco-synthetic capability may be reactivated and expressed at higher levels in the future, with consequences best understood at present by the parasite.
